Dysregulation of cyclin-dependent kinase 7 (CDK7) is a common feature of many tumors, and CDK7 inhibition has been shown to repress colony formation and cell proliferation in breast cancer by elevating expression levels of P53 and GSDME [250]. Here, GSDME is linked to breast cancer.